Anti-DRAM2 monoclonal antibody

Pre-made anti-DRAM2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DRAM2/DRAM2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0729-Ab-1/ GM-Tg-hg-IP0729-Ab-2Anti-Human DRAM2 monoclonal antibodyHuman
GM-Tg-rg-IP0729-Ab-1/ GM-Tg-rg-IP0729-Ab-2Anti-Rat DRAM2 monoclonal antibodyRat
GM-Tg-mg-IP0729-Ab-1/ GM-Tg-mg-IP0729-Ab-2Anti-Mouse DRAM2 monoclonal antibodyMouse
GM-Tg-cynog-IP0729-Ab-1/ GM-Tg-cynog-IP0729-Ab-2Anti-Cynomolgus/ Rhesus macaque DRAM2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0729-Ab-1/ GM-Tg-felg-IP0729-Ab-2Anti-Feline DRAM2 monoclonal antibodyFeline
GM-Tg-cang-IP0729-Ab-1/ GM-Tg-cang-IP0729-Ab-2Anti-Canine DRAM2 monoclonal antibodyCanine
GM-Tg-bovg-IP0729-Ab-1/ GM-Tg-bovg-IP0729-Ab-2Anti-Bovine DRAM2 monoclonal antibodyBovine
GM-Tg-equg-IP0729-Ab-1/ GM-Tg-equg-IP0729-Ab-2Anti-Equine DRAM2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0729-Ab-1/ GM-Tg-hg-IP0729-Ab-2; GM-Tg-rg-IP0729-Ab-1/ GM-Tg-rg-IP0729-Ab-2;
GM-Tg-mg-IP0729-Ab-1/ GM-Tg-mg-IP0729-Ab-2; GM-Tg-cynog-IP0729-Ab-1/ GM-Tg-cynog-IP0729-Ab-2;
GM-Tg-felg-IP0729-Ab-1/ GM-Tg-felg-IP0729-Ab-2; GM-Tg-cang-IP0729-Ab-1/ GM-Tg-cang-IP0729-Ab-2;
GM-Tg-bovg-IP0729-Ab-1/ GM-Tg-bovg-IP0729-Ab-2; GM-Tg-equg-IP0729-Ab-1/ GM-Tg-equg-IP0729-Ab-2
Products NameAnti-DRAM2 monoclonal antibody
Formatmab
Target NameDRAM2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DRAM2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0729-Ag-1Recombinant multi-species DRAM2/ CORD21/ PRO180 protein
    ORF Viral VectorpGMLP004625human DRAM2 Lentivirus plasmid
    ORF Viral VectorvGMLP004625human DRAM2 Lentivirus particle


    Target information

    Target IDGM-IP0729
    Target NameDRAM2
    Gene ID128338,67171,362011,702812,479905,101093200,767922,100058788
    Gene Symbol and Synonyms2010305N14Rik,2610318G18Rik,CORD21,DRAM2,PRO180,™EM77,WWFQ154
    Uniprot AccessionQ6UX65,Q5BK09,Q3ZC48
    Uniprot Entry NameDRAM2_HUMAN,DRAM2_RAT,DRAM2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000156171
    Target ClassificationN/A

    The target: DRAM2, gene name: DRAM2, also named as CORD21, PRO180, ™EM77, WWFQ154. The protein encoded by this gene binds microtubule-associated protein 1 light chain 3 and is required for autophagy. Defects in this gene are a cause of retinal dystrophy. In addition, two microRNAs (microRNA 125b-1 and microRNA 144) can bind to the mRNA of this gene and produce the disease state. [provided by RefSeq, Mar 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.